Evaluation of nonresolving and progressive pneumonia

Seminars in Respiratory Infections

Volumn 18, Issue 2, 2003, Pages 103-111

  Menéndez, Rosario ^b   Perpiñá, Miguel ^b   Torres, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; DISEASE COURSE; EVALUATION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IMMUNE RESPONSE; INCIDENCE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE PROGRESSION; DRUG RESISTANCE, BACTERIAL; EVALUATION STUDIES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0037780625     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kuru T, Lynch JP 3rd: Nonresolving or slowly resolving pneumonia. Clin Chest Med 20:623-651, 1999
2. Kirtland SH, Winterbauer RH: Slowly resolving, chronic, and recurrent pneumonia. Clin Chest Med 12:303-318, 1991
3. Niederman MS, Mandell LA, Anzueto A, et al: Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730-1754, 2001
4. Ortqvist A, Kalin M, Lejdeborn L, et al: Diagnostic fiber-optic bronchoscopy and protected brush culture in patients with community-acquired pneumonia, Chest 97:576-582, 1990
5. Arancibia F, Ewig S, Martinez JA, et al: Antimicrobial treatment failures in patients with community-acquired pneumonia: Causes and prognostic implications. Am J Respir Crit Care Med 162:154-160, 2000
6. Ruiz M, Ewig S, Marcos MA, et al: Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity. Am J Respir Crit Care Med 160:397-405, 1999
7. Alvarez-Lerma F: Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 22:387-394, 1996
8. Crouch Brewer S, Wunderink RG, Jones CB, et al: Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109:1019-1029, 1996
9. Pereira Gomes JC, Pedreira WL Jr, Araujo EM, et al: Impact of BAL in the management of pneumonia with treatment failure: Positivity of BAL culture under antibiotic therapy. Chest 118:1739-1746, 2000
10. Fein AM, Feinsilver SH, Niederman MS: Nonresolving and slowly resolving pneumonia: Diagnosis and management in the elderly patient. Clin Chest Med 14:555-569, 1993
11. Johnson JL: Slowly resolving and nonresolving pneumonia. Questions to ask when response is delayed. Postgrad Med 108:115-123, 2000
12. Fine MJ, Auble TE, Yealy DM, et al: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243-250, 1997
13. Halm EA, Fine MJ, Marrie TJ, et al: Time to clinical stability in patients hospitalized with community-acquired pneumonia: Implications for practice guidelines. JAMA 279:1452-1457, 1998
14. Mittl RL Jr, Schwab RJ, Duchin JS, et al: Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med 149:630-635, 1994
15. Nelson S: Novel nonantibiotic therapies for pneumonia: Cytokines and host defense. Chest 119:419S-425S, 2001
16. Skerrett SJ, Park DR: Anti-inflammatory treatment of acute and chronic pneumonia. Semin Respir Infect 16:76-84, 2001
17. Bonten MJ, Froon AH, Gaillard CA, et al: The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 156:1105-1113, 1997
18. Monton C, Torres A, El-Ebiary M, et al: Cytokine expression in severe pneumonia: A bronchoalveolar lavage study. Crit Care Med 27:1745-1753, 1999
19. Monton C, Ewig S, Torres A, et al: Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: A pilot study. Eur Respir J 14:218-220, 1999
20. Domingo C, Roig J, Planas F, et al: Radiographic appearance of nosocomial Legionnaires' disease after erythromycin treatment. Thorax 46:663-666, 1991
21. Muder RR, Yu VL, Parry MF: The radiologic manifestations of Legionella pneumonia. Semin Respir Infect 2:242-254, 1987
22. Kim CK, Chung CY, Kim JS, et al: Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia. Pediatrics 105:372-378, 2000
23. Kauppinen MT, Saikku P, Kujala P, et al: Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia. Thorax 51:185-189, 1996
24. Lieberman D, Livnat S, Schlaeffer F, et al: IL-1beta and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection 25:90-94, 1997
25. Meduri GU, Kanangat S, Stefan J, et al: Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med 160:961-967, 1999
26. Chen DK, McGeer A, de Azavedo JC, et al: Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 341:233-239, 1999
27. Ferrer M, Ioanas M, Torres A: The evaluation of the non-responding patients with ventilator-associated pneumonia. Clin Pulm Med 8:290-295, 2001
28. Menendez R, Cordero PJ, Santos M, et al: Pulmonary infection with Nocardia species: A report of 10 cases and review. Eur Respir J 10:1542-1546, 1997
29. Feinsilver SH, Fein AM, Niederman MS, et al: Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest 98:1322-1326, 1990
30. Menendez R, Cordoba J, de La Cuadra P, et al: Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med 159:1868-1873, 1999
31. Mares DC, Wilkes DS: Bronchoscopy in the diagnosis of respiratory infections. Curr Opin Pulm Med 4:123-129, 1998
32. De Lassence A, Fleury-Feith J, Escudier E, et al: Alveolar hemorrhage, Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 151:157-163, 1995
33. Fujimura M, Yasui M, Nishi K, et al: Comparison of bronchoalveolar lavage cell findings in complete-resolution pneumonia and delayed-resolution pneumonia. Am J Med Sci 317:222-225, 1999
34. Jacobs JA, De Brauwer EI, Ramsay G, et al: Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: Usefulness of bronchoalveolar fluid cytology. Respir Med 93:571-578, 1999
35. Luna CM, Vujacich P, Niederman MS, et al: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676-685, 1997
36. Niederman MS: Bronchoscopy in nonresolving nosocomial pneumonia. Chest 117:212S-218S, 2000
37. Franquet T: Imaging of pneumonia: Trends and algorithms. Eur Respir J 18:196-208, 2001
38. Tomiyama N, Muller NL, Johkoh T, et al: Acute parenchymal lung disease in immunocompetent patients: Diagnostic accuracy of high-resolution CT. AJR Am J Roentgenol 174:1745-1750, 2000
39. Dunn IJ, Marrie TJ, MacKeen AD, et al: The value of open lung biopsy in immunocompetent patients with community-acquired pneumonia requiring hospitalization. Chest 106:23-27, 1994